TG Therapeutics | TGTX - 普通株資本

株価
33.73
毎日の変更
-0.90 -2.60%
毎月
20.25%
毎年
-8.12%
Q2 予測
32.81




普通株資本 変化する 日付
AbbVie USD 1.77B 1.75B 2025-06
Alaunos Therapeutics USD 2.21M 131K 2025-09
Amgen USD 539M 1000K 2025-12
Ardelyx USD 244.35M 1.38M 2025-12
Arrowhead Research USD 135.7M 2.44M 2025-09
Bayer EUR 982.42M 0 2025-12
Biogen USD 146.7M 200K 2025-09
Corcept Therapeutics USD 105.97M 842K 2025-12
Curis USD 12.93M 12.87M 2025-12
Gilead Sciences USD 1.24B 1000K 2025-12
Infinity Pharmaceuticals USD 90K 1000 2023-06
J&J USD 2.41B 584K 2025-09
Karyopharm Therapeutics USD 18.31M 18.3M 2025-12
Novartis USD 1.91B 10.64M 2025-12
Novavax USD 162.58M 106K 2025-12
PTC Therapeutics USD 81.47M 1.54M 2025-12
Puma Biotechnology USD 5K 0 2024-06
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
TG Therapeutics USD 155.21M 2.81M 2025-09
Verastem USD 77.74M 77.74M 2025-12
Vertex Pharmaceuticals USD 254M 0 2025-12